To better understand the immune response to highly pathogenic avian influenza virus, we compared expression of cytokines in chickens infected with avian influenza virus (A/Vietnam/1203/04) to that in uninfected chickens. Gene expression analyses revealed that influenza disseminated to multiple organs where immune responses could be identified. Among those cytokines influenced by influenza infection were the T helper type (Th)1-associated cytokines interleukin (IL)12 and interferon γ. In addition, a corresponding downregulation of the intracytoplasmic factor GATA3 was identified, whereas the Th2 cytokines IL4 and IL10 did not appear to be impacted by the infection. The inflammatory cytokine IL6 also appeared to be highly upregulated along with type 1 and type 3 interferon. Together, these data indicate that a strong inflammatory and Th1 response occurs after highly pathogenic avian influenza infection in the chicken that has implications for strategies that target the immune system for improving resistance to avian influenza.
Get full access to this article
View all access options for this article.
References
1.
ButtmannM, MerzynC, HofstetterHH, RieckmannP. 2007. TRAIL, CXCL10 and CCL2 plasma levels during long-term interferon-beta treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response. J Neuroimmunol, 190,1–2:170–176.
2.
CameronMJ, RanL, XuL, DaneshA, Bermejo-MartinJF, CameronCM, MullerMP, GoldWL, RichardsonSE, PoutanenSM, WilleyBM, DeVriesME, FangY, SeneviratneC, BosingerSE, PersadD, WilkinsonP, GrellerLD, SomogyiR, HumarA, KeshavjeeS, LouieM, LoebMB, BruntonJ, McGeerAJ, KelvinDJ. 2007. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol, 81,16:8692–8706.
3.
ChanMC, CheungCY, ChuiWH, TsaoSW, NichollsJM, ChanYO, ChanRW, LongHT, PoonLL, GuanY, PeirisJS. 2005. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res, 6:135.
4.
ChrousosGP. 1995. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med, 332,20:1351–1362.
5.
de JongMD, SimmonsCP, ThanhTT, HienVM, SmithGJ, ChauTN, HoangDM, ChauNV, KhanhTH, DongVC, QuiPT, CamBV, Ha doQ, GuanY, PeirisJS, ChinhNT, HienTT, FarrarJ. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med, 12,10:1203–1207.
6.
Del PreteG. 1998. The concept of type-1 and type-2 helper T cells and their cytokines in humans. Int Rev Immunol, 16,3–4:427–455.
7.
DonelanNR, BaslerCF, Garcia-SastreA. 2003. A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol, 77,24:13257–13266.
8.
Garcia-SastreA, EgorovA, MatassovD, BrandtS, LevyDE, DurbinJE, PaleseP, MusterT. 1998. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology, 252,2:324–330.
9.
GiannessiD, ColottiC, MaltintiM, Del RyS, PronteraC, TurchiS, LabbateA, NegliaD. 2007. Circulating heat shock proteins and inflammatory markers in patients with idiopathic left ventricular dysfunction: their relationships with myocardial and microvascular impairment. Cell Stress Chaperones, 12,3:265–274.
10.
HaydenFG, FritzR, LoboMC, AlvordW, StroberW, StrausSE. 1998. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest, 101,3:643–649.
11.
HolzingerD, JornsC, StertzS, Boisson-DupuisS, ThimmeR, WeidmannM, CasanovaJL, HallerO, KochsG. 2007. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J Virol, 81,14:7776–7785.
12.
HwangES, SzaboSJ, SchwartzbergPL, GlimcherLH. 2005. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science, 307,5708:430–433.
13.
JulkunenI, MelenK, NyqvistM, PirhonenJ, SarenevaT, MatikainenS. 2000. Inflammatory responses in influenza A virus infection. Vaccine, 19,Suppl. 1:S32–S37.
14.
JuraJ, WegrzynP, KorostynskiM, GuzikK, Oczko-WojciechowskaM, JarzabM, KowalskaM, PiechotaM, PrzewlockiR, KojA. 2008. Identification of interleukin-1 and interleukin-6-responsive genes in human monocyte-derived macrophages using microarrays. Biochim Biophys Acta, 1779,6–7:383–389.
15.
KaiserL, FritzRS, StrausSE, GubarevaL, HaydenFG. 2001. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol, 64,3:262–268.
16.
KarpalaAJ, LowenthalJW, BeanAG. 2008a. Activation of the TLR3 pathway regulates IFNbeta production in chickens. Dev Comp Immunol, 32,4:435–444.
KatzJM, LuX, FraceAM, MorkenT, ZakiSR, TumpeyTM. 2000. Pathogenesis of and immunity to avian influenza A H5 viruses. Biomed Pharmacother, 54,4:178–187.
19.
KatzeMG, HeY, GaleMJr.2002. Viruses and interferon: a fight for supremacy. Nat Rev Immunol, 2,9:675–687.
20.
KobasaD, JonesSM, ShinyaK, KashJC, CoppsJ, EbiharaH, HattaY, KimJH, HalfmannP, HattaM, FeldmannF, AlimontiJB, FernandoL, LiY, KatzeMG, FeldmannH, KawaokaY. 2007. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature, 445,7125:319–323.
21.
KopfM, BaumannH, FreerG, FreudenbergM, LamersM, KishimotoT, ZinkernagelR, BluethmannH, KohlerG. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature, 368,6469:339–342.
22.
LienenlukeB, ChristB. 2007. Impact of interleukin-6 on the glucose metabolic capacity in rat liver. Histochem Cell Biol, 128,4:371–377.
23.
MizuguchiM, YamanouchiH, IchiyamaT, ShiomiM. 2007. Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand, 115,4:45–56.
24.
MunderM, MalloM, EichmannK, ModolellM. 1998. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J Exp Med, 187,12:2103–2108.
25.
NagaiT, DevergneO, MuellerTF, PerkinsDL, van SeventerJM, van SeventerGA. 2003. Timing of IFN-beta exposure during human dendritic cell maturation and naive Th cell stimulation has contrasting effects on Th1 subset generation: a role for IFN-beta-mediated regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation. J Immunol, 171,10:5233–5243.
26.
NawijnMC, DingjanGM, FerreiraR, LambrechtBN, KarisA, GrosveldF, SavelkoulH, HendriksRW. 2001. Enforced expression of GATA-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo. J Immunol, 167,2:724–732.
27.
O'SheaJJ, PaulWE. 2002. Regulation of T(H)1 differentiation—controlling the controllers. Nat Immunol, 3,6:506–508.
28.
OsterlundP, VeckmanV, SirenJ, KlucherKM, HiscottJ, MatikainenS, JulkunenI. 2005. Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J Virol, 79,15:9608–9617.
29.
PeirisJS, YuWC, LeungCW, CheungCY, NgWF, NichollsJM, NgTK, ChanKH, LaiST, LimWL, YuenKY, GuanY. 2004. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet, 363,9409:617–619.
30.
PerkinsLE, SwayneDE. 2001. Pathobiology of A/chicken/Hong Kong/220/97 (H5N1) avian influenza virus in seven gallinaceous species. Vet Pathol, 38,2:149–164.
31.
RuschplerP, StiehlP. 2002. Shift in Th1 (IL-2 and IFN-gamma) and Th2 (IL-10 and IL-4) cytokine mRNA balance within two new histological main-types of rheumatoid-arthritis (RA)Cell Mol Biol (Noisy-Le-Grand), 48,3:285–293.
32.
SalomonR, HoffmannE, WebsterRG. 2007. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci U S A, 104,30:12479–12481.
33.
SarenevaT, MatikainenS, KurimotoM, JulkunenI. 1998. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. J Immunol, 160,12:6032–6038.
34.
ScholtissekC. 1995. Molecular evolution of influenza viruses. Virus Genes, 11,2–3:209–215.
35.
SinigagliaF, D'AmbrosioD, RoggeL. 1999. Type I interferons and the Th1/Th2 paradigm. Dev Comp Immunol, 23,7–8:657–663.
36.
SkonerDP, GentileDA, PatelA, DoyleWJ. 1999. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. J Infect Dis, 180,1:10–14.
37.
StarkGR, KerrIM, WilliamsBRG, SilvermanRH, SchreiberRD. 1998. How cells respond to interferons. Annu Rev Biochem, 67,1:227–264.
38.
SuzukiK, OkadaH, ItohT, TadaT, MaseM, NakamuraK, KuboM, TsukamotoK. 2009. Association of increased pathogenicity of Asian H5N1 highly pathogenic avian influenza viruses in chickens with highly efficient viral replication accompanied by early destruction of innate immune responses. J Virol, 83,15:7475–7486.
39.
SvitekN, RuddPA, ObojesK, PilletS, von MesslingV. 2008. Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. Virology, 376,1:53–59.
40.
SzretterKJ, GangappaS, LuX, SmithC, ShiehWJ, ZakiSR, SambharaS, TumpeyTM, KatzJM. 2007. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol, 81,6:2736–2744.
41.
ToKF, ChanPK, ChanKF, LeeWK, LamWY, WongKF, TangNL, TsangDN, SungRY, BuckleyTA, TamJS, ChengAF. 2001. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol, 63,3:242–246.
42.
TrinchieriG. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol, 3,2:133–146.
43.
Van Der SluijsKF, Van EldenLJ, ArensR, NijhuisM, SchuurmanR, FlorquinS, KwakkelJ, AkiraS, JansenHM, LutterR, Van Der PollsT. 2005. Enhanced viral clearance in interleukin-18 gene-deficient mice after pulmonary infection with influenza A virus. Immunology, 114,1:112–120.
44.
WangX, LiM, ZhengH, MusterT, PaleseP, BegAA, Garcia-SastreA. 2000. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol, 74,24:11566–11573.
45.
WatfordWT, MoriguchiM, MorinobuA, O'SheaJJ. 2003. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev, 14,5:361–368.
46.
WeberJ, YangJC, TopalianSL, ParkinsonDR, SchwartzentruberDS, EttinghausenSE, GunnH, MixonA, KimH, ColeDothers1993. Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol, 11,3:499–506.
47.
WilliamsBR. 1999. PKR; a sentinel kinase for cellular stress. Oncogene, 18,45:6112–6120.
48.
WohllebenG, ErbKJ. 2004. The absence of IFN-gamma leads to increased Th2 responses after influenza A virus infection characterized by an increase in CD4+ but not CD8+ T cells producing IL-4 or IL-5 in the lung. Immunol Lett, 95,2:161–166.
49.
ZengH, GoldsmithC, ThawatsuphaP, ChittaganpitchM, WaicharoenS, ZakiS, TumpeyTM, KatzJM. 2007. Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type i interferon response in polarized human bronchial epithelial cells. J Virol, 81,22:12439–12449.
50.
ZhuJ, MinB, Hu-LiJ, WatsonCJ, GrinbergA, WangQ, KilleenN, UrbanJFJr., GuoL, PaulWE. 2004. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol, 5,11:1157–1165.
